Table 3.
Model 1 | Model 2 | Model 3 | Model 4 | |||||
---|---|---|---|---|---|---|---|---|
OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | |
SPPB <10 | ||||||||
Tender point count | 1.16 | 1.08–1.24 | - | 1.14 | 1.06–1.22 | 1.09 | 1.01–1.17 | |
McGill pain | ||||||||
no pain | - | 1.0 | 1.0 | 1.0 | ||||
single site | - | 1.13 | 0.65–1.95 | 1.09 | 0.62–1.92 | 1.25 | 0.67–2.31 | |
multisite | - | 1.56 | 1.05–2.33 | 1.39 | 0.92–2.11 | 1.07 | 0.67–1.70 | |
widespread | - | 2.27 | 1.20–4.29 | 1.85 | 0.96–3.57 | 1.23 | 0.58–2.62 | |
Gait speed | ||||||||
Tender point count | 1.18 | 1.10–1.26 | - | 1.17 | 1.09–1.25 | 1.14 | 1.05–1.24 | |
McGill pain | ||||||||
no pain | - | 1.0 | 1.0 | 1.0 | ||||
single site | - | 1.00 | 0.52–1.91 | 0.94 | 0.48–1.84 | 1.14 | 0.55–2.39 | |
multisite | - | 1.36 | 0.86–2.15 | 1.19 | 0.74–1.91 | 0.86 | 0.50–1.48 | |
widespread | - | 2.07 | 1.03–4.14 | 1.67 | 0.81–3.45 | 0.99 | 0.42–2.30 | |
Mobility difficulty | ||||||||
Tender point count | 1.11 | 1.04–1.18 | - | 1.08 | 1.01–1.15 | 1.01 | 0.94–1.10 | |
McGill pain | ||||||||
no pain | - | 1.0 | 1.0 | 1.0 | ||||
single site | - | 1.12 | 0.62–2.01 | 1.08 | 0.59–1.98 | 1.53 | 0.74–3.14 | |
multisite | - | 2.43 | 1.61–3.67 | 2.34 | 1.53–3.59 | 2.01 | 1.21–3.34 | |
widespread | - | 3.77 | 1.05–7.17 | 3.52 | 1.82–6.81 | 2.47 | 1.09–5.62 |
Model 1 includes tender point count, adjusted for age, gender, and race. Model 2 includes pain categories, adjusted for age, gender, race. Model 3 included both tender point count and pain categories, adjusted for age, gender, and race. Model 4 includes all variables from model 3 and education, Body Mass Index (BMI), self reported chronic conditions: heart disease, diabetes, spinal stenosis/disc disease, gout, asthma, and stroke; daily use of analgesic medication, number of medications, depression, and blocks walked per week.
CI=confidence interval; OR=odds ratio; SPPB=Short Physical Performance Battery